Company Filing History:
2 out of 2 
2 out of 3 
1 out of 1 Years Active: 1991-1992
Title: Olav Smidsrod: Innovator in Cytokine Production and Therapeutic Applications
Introduction
Olav Smidsrod is a notable inventor based in Trondheim, Norway. He has made significant contributions to the field of biopolymers and cytokine production, holding a total of 3 patents. His work focuses on the therapeutic applications of polysaccharides and their effects on human health.
Latest Patents
Smidsrod's latest patents include innovative materials and methods for stimulating cytokine production. One of his inventions, titled "Diequatorially bound .beta.-1, 4 polyuronates and use of same for," describes a method that utilizes various polysaccharides to induce human monocytes to produce cytokines. This invention has potential therapeutic applications as vaccine adjuvants and components, enhancing antibody production in response to vaccine antigens. Another significant patent involves the use of oligomers and polymers of .alpha.1-4 linked L-guluronic acid residues to inhibit the production of interleukin-1, interleukin-6, and tumor necrosis factor, which can alleviate various disease conditions.
Career Highlights
Throughout his career, Olav Smidsrod has worked with notable organizations such as Nobipols Forskningsstiftelse and Protan Biopolymer AS. His research has contributed to advancements in the understanding of cytokine production and its implications for health and disease.
Collaborations
Smidsrod has collaborated with esteemed colleagues, including Marit Otterlei and Terje Espevik. These partnerships have furthered his research and innovation in the field of biopolymers and cytokine modulation.
Conclusion
Olav Smidsrod's work exemplifies the intersection of innovation and health, with his patents paving the way for new therapeutic approaches. His contributions to cytokine production and biopolymer research continue to impact the scientific community and hold promise for future medical applications.